Our Mission Statement

HTRS is the leading North American professional society dedicated to research, mentoring, workforce development, and continuing medical education for physicians, investigators, and all health care professionals interested in advancing care for people with hemostatic and thrombotic disorders.

Please join us!

Check out our membership levels and benefits:





COVID-19 UPDATE: THSNA 2020 will be held virtually October 27-29, 2020. Registration is FREE. The next ConECCTOR Meeting will be held virtually via Zoom on Thursday, August 27, 9-10:30 AM CT. For more info, email [email protected].


Our next Trainee Workshop will take place virtually December 2-3, 2020, following the recent announcement that ASH will take place virtually December 3-8, 2020.  The HTRS Research Colloquium now is scheduled for March 9-10, 2021, to precede the HTRS Scientific Symposium March 11-13, 2021. The format is TBD.  Any questions, please email [email protected].




Registration and Call for Abstracts for the HTRS 2021 Scientific Symposium will open Wednesday, August 26, 2020.  The Call for Abstracts will close on Thursday, October 15, 2020.  Stay tuned for more details to come.


Read more


Read more

Workforce Development

Read more

Continuing Education

Read more




FWGBD Conference: Sept. 24-25, 2020

Register now for the inaugural educational conference of the Foundation for Women & Girls with Blood Disorders (FWGBD) to take place virtually on September 24-25, 2020 with on-demand access for six months thereafter. This conference is for healthcare providers dedicated to the care and support of women and girls with blood disorders.

Target audience includes:

  • Clinicians and physician-researchers (MDs, DOs, MD/PhDs)
  • Trainees (MD/DOs who are residents and fellows)
  • Basic and translational scientists (Post-docs and PhDs)
  • Nurses, nurse practitioners, and physician assistants
  • Pharmacists and more

What you will find at FWGBD:

  • Inspiring speakers featuring innovative and current best-practice strategies by leading experts
  • Free continuing medical education (CME) credits
  • Dedicated sessions built around multidisciplinary care of women and girls with bleeding disorders
  • Opportunity to engage and interact with healthcare leaders and professionals

For more info, CLICK HERE.

To register: CLICK HERE*

If you have an FWGBD/HTRS joint membership, you are entitled to complimentary registration.  Log in to the Members Only section of this website for discount code.



CORONAVIRUS (COVID-19) HTRS UPDATE: In light of public health recommendations regarding the COVID-19 pandemic from both the WHO and the CDC, the THSNA 2020 Summit will be held virtually October 27-29, 2020.  To register and for more info, CLICK HERE.

Our next Trainee Workshop now will take place Pre-ASH on December 2-3, 2020, whereas the Research Colloquium has been rescheduled for March 9-10, 2021, to precede the HTRS Scientific Symposium that will be held March 11-13, 2021.  Further details to come.

Any questions, email [email protected].


2021 HTRS Research Colloquium

The 2020 second biennial HTRS Research Colloquium has been rescheduled for March 9-10, 2021, and may take place at the Loews Coronado Bay in San Diego, CA. The format may offer a combination of live and virtual presentations. Stay tuned for more details as they develop. 

In any case, it will be a dynamic meeting focused on professional development and networking in benign hematology for:

  • Basic Scientists
  • Translational Researchers
  • Clinicians/Physician-Scientists
  • Location: Pre-THSNA Summit 2020 at the Hyatt Regency Chicago

Colloquium Website: DETAILS TO COME


2021 HTRS Scientific Symposium

The 2021 HTRS Scientific Symposium is currently planned for March 11-13, 2021, at the Loews Coronado Bay, San Diego, CA.  Stay tuned for detail regarding format, which will likely feature live and virtual presentations.  

Registration and Call for Abstracts will open Wednesday, August 26, 2020.  The Call for Abstracts will close on Thursday, October 15, 2020.  Further details forthcoming.


National Hemophilia Foundation

The National Hemophilia Foundation (NHF) offers funding opportunities for investigators at all career stages who are interested in research or clinical projects that investigate inherited bleeding disorders.

Bridge Award
Funding amount:$125,000 for one year
Application Deadline: August 16, 2020

If you applied for an NIH R01 grant or equivalent federal grant but were denied funding, NHF’s Bridge Award can help you continue your research. This grant seeks to help experienced investigators continue their critical research into inheritable bleeding disorders and contribute to their retention in bleeding disorders investigation.

Questions? Please see the NHF Funding Opportunities Announcement or contact NHF's Research Department, [email protected]


18th Midwest Platelet Conference

September 21-23, 2020: University of Michigan, Ann Arbor MI

For more info, CLICK HERE



NHLBI News: Blueprint, Strategies and Tools for Future Factor VIII Inhibitor-Related Research

Factor VIII Inhibitor State of the Science Workshop Proceedings were published in the July 2019 edition of Hemophilia - Volume 24, Issue 4



Abstracts from 2019 Symposium published in Haemophilia

The Abstracts from the HTRS/NASTH 2019 Scientific Symposium were published in Haemophilia, the official journal of HTRS. 



Podcast: NHLBI Resources and Grants for Hematologists with Drs. DiMichele and Hoots

How to maximize research training and funding opportunities for non-malignant hematology and blood science investigators is the subject of this free podcast, in which Dr. Donna DiMichele and Dr. Keith Hoots of the National Heart, Lung, and Blood Institute (NHLBI) talk about NHLBI and National Institutes of Health resources and grants available to hematologists.  



Join a Registry


The Children’s Hospital-Acquired Thrombosis (CHAT) Study


Dr. Anthony Fauci praises HTRS Member Lisa Baumann Kreuziger for her work on national COVID-19 panel    

Dr. Lisa Baumann Kreuziger, MD, MS, Medical Director at the Versiti Blood Center of Wisconsin, was praised in a personal letter of gratitude from White House advisor and director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci.

A hematology expert, Dr. Baumann Kreuziger is serving on a national COVID-19 panel that recommends the best treatment options for people with the virus.  The guidelines have been developed to inform clinicians how to care for patients with COVID-19, she says. 

"You responded in an exceptional way and worked tirelessly to develop an outstanding initial set of guidelines in two weeks," wrote Dr. Fauci.  "In the first week after their release on April 21, there were more than 1 million page views, highlighting the importance of your work.  Thank you again for your contributions to this panel, for your outstanding work in caring for patients and for all the additional ways you are helping to respond to this pandemic during this most extraordinary time."

Says Dr. Baumann Kreuziger, "I was honored and humbled to be part of a group of experts to establish treatment recommendations.  The guidelines have provided a review of evidence on which doctors can treat patients and develop research."


2020 HTRS Trainee Workshop 'Building a Career in Hemostasis and Thrombosis' - postponed to December 2020

Postponed until December 2-3, 2020, this Workshop may take place prior to ASH 2020 at the Loews Coronado Bay Resort in Coronado, CA.  It is open to 30 MDs or DOs in training and offers a dynamic mix of case presentations by attending trainees, interactive presentations by faculty, small group breakout sessions, and  networking time.

For more info, click on the Education & Events tab above.

Questions? Email [email protected].


2020 HTRS/ATHN Dataset Research Engagement and ATHN Mentorship ("DREAM") Award: Pre-Proposal Application deadline has passed

Together, we're helping turn dreams into reality. The DREAM Award is offered through the collaboration of HTRS and ATHN and supported by an independent medical educational grant from Takeda. Key details:

  • Applicants residing in the U.S. and working at U.S.-based, ATHN-affiliated HTCs are eligible to apply for a 2020 DREAM Award.  
  • The award offers funding of $50,000 USD per recipient for projects lasting up to one year and $100,000 USD per recipient for projects lasting up to two years



2020 HTRS Student Research Awards: Deadline has passed

The deadline has passed for  the Hemostasis and Thrombosis Research Society (HTRS) Student Research Award, an 8- to 10-week program for medical, PhD, MD/PhD, or PharmD students working on targeted research projects in hemostasis and thrombosis. Proposed projects may be lab-based, clinical or epidemiologic in design. The program includes a $5,000 award stipend plus a $2,000 travel allowance, collaboration with a research mentor, and a presentation at a 2021 professional meeting. Watch for more details late 2020 for next year's program.